SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

ICRA reaffirms CP/STD programme of Unichem Laboratories

16 Aug 2011 Evaluate

Credit rating agency, ICRA has reaffirmed the A1+ rating assigned to the Rs 15.0 crore Commercial Paper (CP) / Short Term Debt (STD) programme of Unichem Laboratories.

The rating reaffirmation takes into account the company’s established presence in the domestic formulation business with sizeable exposure towards the fast growing and relatively high margin chronic therapeutic segments.

Unichem Laboratories is engaged in manufacturing formulations, pharmaceuticals and APIs. The company offers products in therapeutic areas like gastro-intestinal, cardiovascular, diabetes, psychiatry, neurology, anti-bacterial, anti-infective and pain management, among others.

Unichem Lab Share Price

350.85 4.85 (1.40%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×